HC Wainwright Reiterates “Buy” Rating for Precision BioSciences (NASDAQ:DTIL)
Precision BioSciences (NASDAQ:DTIL – Get Free Report)‘s stock had its “buy” rating reaffirmed by HC Wainwright in a research report issued on Wednesday,Benzinga reports. They currently have a $60.00 price objective on the stock. Separately, BMO Capital Markets upgraded Precision BioSciences from a “market perform” rating to an “outperform” rating and set a $34.00 price […]
Precision BioSciences (NASDAQ:DTIL – Get Free Report)‘s stock had its “buy” rating reaffirmed by HC Wainwright in a research report issued on Wednesday,Benzinga reports. They currently have a $60.00 price objective on the stock. Separately, BMO Capital Markets upgraded Precision BioSciences from a “market perform” rating to an “outperform” rating and set a $34.00 price […]
